Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers

Press/Media: Press / Media

PeriodSep 18 2020 → Sep 20 2020

Media coverage

15

Media coverage

  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletPipelineReview
    CountrySpain
    Date9/20/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletMorningstar.com
    CountryUnited States
    Date9/18/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletTMC Net
    CountryUnited States
    Date9/18/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletForex TV
    CountryUnited States
    Date9/18/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletStocksNewsFeed.com
    CountryUnited States
    Date9/18/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletMarketScreener.com
    CountryUnited States
    Date9/18/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletMarkets Business Insider
    CountryUnited States
    Date9/18/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletCustomer Zone 360.com
    CountryUnited States
    Date9/18/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletJotup
    CountryUnited States
    Date9/18/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletNasdaq
    CountryUnited States
    Date9/18/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletBiotechgate
    CountrySwitzerland
    Date9/18/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletUSA Life Sciences Database
    CountrySwitzerland
    Date9/18/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletGlobeNewswire
    CountryUnited States
    Date9/18/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletEIN Presswire
    CountryUnited States
    Date9/18/20
    PersonsAndrew Brenner
  • TitleImmunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
    Media name/outletBizWire Express
    CountryIndia
    Date9/18/20
    PersonsAndrew Brenner